LG Chem is set to establish a $3 billion battery cathode factory for electric vehicles (EVs) in Tennessee. Additionally, it has inked a long-term cathode material supply contract with General Motors (GM) worth a staggering $19 billion.
Pratt & Whitney announced a $20 million investment to grow its manufacturing capacity in Singapore for the production of Pratt & Whitney GTF™ engine high pressure turbine (HPT) disks.
SK hynix Inc. announced today that it has established a roadmap to actively utilize recycled1 and renewable2 materials in production, marking the first case that a semiconductor company lays out such mid- to long-term plan.
Millstone Medical Outsourcing announces the groundbreaking for a third cleanroom facility expansion at its Fall River, MA headquarters.
The Pennsylvania Biotechnology Center partnership offers biotech residents flexible, plug & play lab and research...
Joint marketing and technology collaboration will leverage strengths of two market leaders to provide nanoimprint lithography development kits and foster industrial-scale implementation
ILC Doveror specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced the launch of Water for Injection (WFI) for the biotherapeutics market.
SteriPack Group, a leading global contract manufacturer, today announced it has expanded its high-quality sample collection line with two new swab products.
Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide
SK pharmteco, is pleased to announce $35m investment for the initial phase of an expansion plan for SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant.
ISPE announced the release of the ISPE Good Practice Guide: Membrane-Based Water for Injection Systems. This Guide provides expert guidance on the design, operation, maintenance, and quality aspects of membrane-based water for injection (WFI) systems, including generation, storage, and distribution.
Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.